{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifgttppfjzjc62a3ibpkxvwe2wfro2jdnzijmvivg2kdrwwbawuju",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3mek5pfjfuxm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic7a2izpd572fnj5nklb5paa7k3v6462kvm4uzbxjbikpu4szjv6y"
    },
    "mimeType": "image/jpeg",
    "size": 401271
  },
  "path": "/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html",
  "publishedAt": "2026-02-10T23:00:07.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Drugs (Pharmaceuticals)",
    "Vaccination and Immunization",
    "Influenza",
    "Regulation and Deregulation of Industry",
    "Clinical Trials",
    "RNA (Ribonucleic Acid)",
    "Food and Drug Administration",
    "Moderna Inc",
    "Prasad, Vinayak K",
    "Kennedy, Robert F Jr",
    "Trump, Donald J"
  ],
  "textContent": "The vaccine maker said the U.S. regulator rejected its request to seek approval for a new product using mRNA technology, which Health Secretary Robert F. Kennedy Jr. has sharply criticized.",
  "title": "F.D.A. Refuses to Review Moderna Flu Vaccine"
}